Linnik; Matthew D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Linnik; Matthew D..The latest application filed is for "engineered antibody compounds and conjuates thereof".

Company Profile

1.3.20

Linnik; Matthew D. - Solana Beach CA
Linnik; Matthew D - Solana Beach CA
Linnik; Matthew D. - San Diego CA
Linnik; Matthew D. - Cincinnati OH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Engineered Antibody Compounds and Conjuates Thereof App 20200155702 - Bacica; Michael James ; et al.	2020-05-21
Treatment Of Pruritus App 20180201673 - Linnik; Matthew D	2018-07-19
Inhibitors Of Semicarbazide-sensitive Amine Oxidase (ssao) And Vap-1 Mediated Adhesion Useful For Treatment And Prevention Of Diseases App 20110269811 - WANG; Eric Yanjun ; et al.	2011-11-03
Methods Of Treating Systemic Lupus Erythematosus In Individuals Having Significantly Impaired Renal Function App 20100152281 - LINNIK; Matthew D. ; et al.	2010-06-17
Inhibitors Of Semicarbazide-sensitive Amine Oxidase (ssao) And Vap-1 Mediated Adhesion Useful For Treatment And Prevention Of Diseases App 20090203764 - WANG; Eric Yanjun ; et al.	2009-08-13
Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases App 20070293548 - Wang; Eric Yanjun ; et al.	2007-12-20
Methods Of Improving Health-related Quality Of Life In Individuals With Systemic Lupus Erythematosus App 20070218072 - Strand; Vibeke ; et al.	2007-09-20
Methods Of Treating And Monitoring Systemic Lupus Erythematosus In Individuals App 20070191297 - LINNIK; Matthew D. ; et al.	2007-08-16
Methods Of Treating Proteinuria By Reducing Double-stranded Dna Antibodies App 20070179111 - LINNIK; Matthew D.	2007-08-02
Methods of treating proteinuria by reducing double-stranded DNA antibodies App 20060229270 - Linnik; Matthew D.	2006-10-12
Methods of treating systemic lupus erythematosus in individuals having significantly impaired renal function App 20060217333 - Linnik; Matthew D. ; et al.	2006-09-28
Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereof Grant 7,081,242 - Linnik , et al. July 25, 2	2006-07-25
Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereof App 20060142229 - Linnik; Matthew D. ; et al.	2006-06-29
Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment of diseases App 20050096360 - Salter-Cid, Luisa Maria ; et al.	2005-05-05
Therapeutic and diagnostic domain 1 .beta.2GPI polypeptides and methods of using same Grant 6,858,210 - Marquis , et al. February 22, 2	2005-02-22
Therapeutic and diagnostic domain 1 beta2GP1 polypeptides and methods of using same App 20050004351 - Marquis, David M. ; et al.	2005-01-06
Methods of treating and monitoring systemic lupus erythematosus in individuals App 20040258683 - Linnik, Matthew D. ; et al.	2004-12-23
Methods of improving health-related quality of life in individuals with systemic lupus erythematosus App 20040208864 - Strand, Vibeke ; et al.	2004-10-21
Human Nerve Growth Factor Exon 1 And Exon 3 Promoters App 20030192065 - LINNIK, MATTHEW D. ; et al.	2003-10-09
Human nerve growth factor exon 1 and exon 3 promoters App 20030159159 - Linnik, Matthew D. ; et al.	2003-08-21
Methods of treating systemic lupus erythematosus in individuals having significantly impaired renal function App 20030114405 - Linnik, Matthew D. ; et al.	2003-06-19
Methods of treating antibody-mediated pathologies using agents which inhibit CD21 App 20030077273 - Linnik, Matthew D. ; et al.	2003-04-24
Substituted oxazolidine calpain and/or cathepsin B inhibitors Grant 5,691,368 - Peet , et al. November 25, 1	1997-11-25

Company Registrations

SEC

0001237521

LINNIK MATTHEW D

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.